EPGNF 주가 차트
EPGNF 주가 예측
Epigenomics AG
$0
0%
$0
종가: Jun 18, 16:00:00 GMT-4
$0
0%
$0
애프터마켓: Jun 18, 20:00:00 GMT-4
뒤로
Epigenomics AG (EPGNF) 주가 예측
주요 통계
이전 종가
--
시가
--
일일 범위
-
52주 범위
-
거래량
--
평균 거래량
--
배당수익률
--
EPS(TTM)
--
시가총액
--
Epigenomics AG란 무엇인가요?
Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. The company is headquartered in Heidelberg, Baden-Wuerttemberg and currently employs 3 full-time employees. The company went IPO on 2004-07-19. The company develops and commercializes blood-based diagnostic products across multiple cancer indications. The firm's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the Company offers services related to research, product development, regulatory approval and manufacturing of in-vitro diagnostic (IVD) products. The company also offers Epi proLung, a blood-based test that detects the presence of lung cancer in blood plasma. The firm is present in Europe and the United States.
